Chemical Structure (Chem Struc)
Cerianna Injection
Product Images NDC 72874-001
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Cerianna (NDC 72874-001). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Ge Healthcare Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Spl V10 Label Leadcontainer
CERIANNAT™ (Fluoroestradiol F 18) Injection is a medication for intravenous diagnostic use. It contains sodium ascorbate and sodium chloride. The usual dosage is indicated in the prescribing information. The half-life of the medication is 109.7 minutes. The correct dosage should be calculated based on the date and time of calibration. The medication should not be used if it contains particulate matter or cloudy. It is distributed by Zionexa US Corp and is considered a radioactive material. It should be stored upright in a shielded container at a temperature ranging from 20°C to 25°C.*
Spl V10 Label Vial
CERIANNA™ is a radioactive injection containing Fluoroestradiol F 18 with a concentration range of 148 MBq/mL to 3.700 MBg/mL. It is intended for intravenous administration only and is to be stored at 20°C to 25°C (68°F to 77°F) in a shielded container with ethanol no more than 3.2% w/v. The usual dosage information is available in the prescribing information. It is important not to use if the solution appears cloudy or if it contains particulate matter. The injection is distributed by Zionexa US Corp and is a radioactive material with a manufacturing date and lot number, and an expiration date and time specified.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
